Brief: Simcere Pharmaceutical Announces Exclusive License Deal With Idorsia For Insomnia Drug

Simcere Pharmaceutical

16/11/2022 01:25

Nov 16 (Reuters) - Simcere Pharmaceutical Group Ltd
 2096.HK :
    * EXCLUSIVE LICENSE AGREEMENT WITH IDORSIA FOR INSOMNIA DRUG
DARIDOREXANT
    * UNDER DEAL, GROUP TO BE GRANTED EXCLUSIVE RIGHT TO DEVELOP
AND
COMMERCIALIZE INSOMNIA DRUG DARIDOREXANT IN GREATER CHINA
    * UNDER AGREEMENT, IDORSIA WILL RECEIVE A US$30 MILLION
UPFRONT
PAYMENT
    * UNDER DEAL, ELIGIBLE TO RECEIVE ADDITIONAL MILESTONE
PAYMENT OF
US$20 MILLION UPON REGULATORY APPROVAL BY CHINA NMPA

Further company coverage:  2096.HK 
 ((Reuters.Briefs@thomsonreuters.com;))